In the midst of the perfect storm in senior care—complex patients, high expectations, tight budgets and limited infrastructure—the need for effective collaboration is more critical than ever. That ...
This collaborative was convened to catalogue current efforts to advance the science of patient input, identify critical gaps in the knowledge base and other barriers that impede progress, prioritize ...
Oxford, UK – 1 May 2013: Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, announces that it has signed an agreement with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback